Sharp, Clear Vision In The Day...
…That Progresses Into The Night. It’s Possible.
Achieve excellent night vision with EVO ICL.
For All Life’s Little Moments
Experience more of what life has to offer every single minute of your day and night without compromising your night vision.
Enjoy The Drive, Even At Night
Leave your glasses at home, hit the open roads, and still be able to see clearly while driving at night. Day or night, you can rely on EVO ICL.
Not Only Nighttime, But Short-sightedness
Catch the movies and shows you love even from a distance. EVO ICL corrects and reduces short-sightedness (myopia) so you’re free to enjoy even more.
It Only Takes 30 Minutes
The EVO ICL procedure is minimally invasive and the lens is implanted through a small opening allowing for a quick procedure and recovery time. With over 2,000,000 lenses distributed worldwide, EVO ICL is quickly becoming a vision correction procedure of choice for many people around the world.
Ready to Discover Visual Freedom With EVO ICL? Find a Doctor Today
Important Safety Information
EVO & EVO TICL is designed for the correction of moderate to high near-sightedness (-0.5 to -20.0 dioptres (D)) and the reduction of near-sightedness in patients with up to -20 dioptres (D) of near-sightedness with less than or equal to 6.0 dioptres (D) of astigmatism. It is indicated for patients who are 21 to 45 years of age. In order to be sure that your surgeon will use a EVO with the most adequate power for your eye, your near-sightedness should be stable for at least a year before undergoing eye surgery. EVO surgery has been documented to safely and effectively correct near-sightedness between -0.5 dioptres (D) to -20.0 dioptres (D) and partially correct near-sightedness up to -20 dioptres in eyes with up to 6.0(D) of astigmatism. If you have near-sightedness within these ranges, EVO surgery may improve your distance vision without eyeglasses or contact lenses. EVO surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. EVO is not intended to correct any astigmatism you may have. Implantation of the EVO is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care provider. The following represent potential complications/adverse events reported in conjunction with refractive surgery in general: conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, Visian ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO surgery you should have a complete eye examination and talk with your eye care professional about EVO surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
3. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
4. Parkhurst G. A Prospective Comparison of Phakic Collamer Lenses and Wavefront-Optimized Laser-Assisted In Situ Keratomileusis for Correction of Myopia. Clinical Ophthalmology 2013: 10: 1209–1215.
5a. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
5b. Gimbel, Howard V et al. Management of myopic astigmatism with phakic intraocular lens implantation. Journal of Cataract & Refractive Surgery , Volume 28 , Issue 5 , 883 – 886.